Results
622
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
622 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
FME | €37.95 | 4.0% | -7.1% | €11.2b | €38.53 | PE21.2x | E21.9% | 3.1% | ||
APOLLOHOSP | ₹7,234.00 | 2.1% | 40.8% | ₹1.0t | ₹7,219.93 | PE100.3x | E32.3% | 0.2% | ||
508869 | ₹7,239.00 | 2.1% | 40.9% | ₹1.0t | ₹7,224.92 | PE100.3x | E32.3% | 0.2% | ||
TBH | US$216.00 | 0% | 16.8% | US$11.6b | US$226.34 | PE43.9x | E21.3% | 0.6% | ||
MAXHEALTH | ₹994.75 | -6.9% | 75.3% | ₹967.6b | ₹937.80 | PE91.8x | E27.6% | 0.2% | ||
543220 | ₹995.30 | -6.8% | 75.4% | ₹967.6b | ₹938.32 | PE91.8x | E27.6% | 0.2% | ||
PUREHEALTH | د.إ3.58 | -2.2% | n/a | د.إ39.8b | د.إ6.08 | PE64.5x | E29.7% | n/a | ||
GM0N | US$63.00 | 0% | 32.9% | US$9.6b | US$70.76 | PE235.1x | E53.3% | n/a | ||
GMED * | US$1,341.00 | 0% | n/a | US$9.6b | US$1,506.18 | PE235.1x | E53.3% | n/a | ||
G2ME34 | US$49.20 | 1.5% | n/a | US$9.6b | US$55.26 | PE235.1x | E53.3% | n/a | ||
PMDI.Y | AU$13.25 | 0% | n/a | AU$13.8b | AU$10.59 | PE197.4x | E18.6% | 0.3% | ||
HSIC | US$65.78 | 2.2% | -6.2% | US$9.3b | US$65.83 | PE26.4x | E24.2% | n/a | ||
0L3C | US$72.92 | 1.9% | -1.6% | US$9.3b | US$72.97 | PE26.4x | E24.2% | n/a | ||
A091990 | ₩75,900.00 | 0% | 26.9% | ₩11.9t | ₩89,111.11 | PE276.1x | E63.3% | 0.2% | ||
1CB | US$28.20 | 1.4% | 55.8% | US$9.0b | US$28.01 | PS2.6x | E70.4% | n/a | ||
DEMA | DKK 35.80 | -0.3% | -8.8% | DKK 58.0b | DKK 40.46 | PE22.9x | E12.5% | n/a | ||
6HL | US$18.70 | -2.1% | 0% | US$8.3b | US$29.88 | PE82.6x | E29.6% | n/a | ||
300832 | CN¥73.00 | 6.6% | 14.9% | CN¥57.4b | CN¥83.00 | PE31.7x | E23.2% | 1.4% | ||
300832 | CN¥73.00 | 6.6% | 14.9% | CN¥57.4b | CN¥83.00 | PE31.7x | E23.2% | 1.4% | ||
PEN * | US$3,516.00 | 0% | -28.3% | US$7.9b | US$3,393.69 | PE556x | E44.2% | n/a | ||
LNTH | US$107.36 | -2.4% | 54.5% | US$7.5b | US$144.55 | PE17.4x | E16.2% | n/a | ||
PEN | US$191.55 | -1.8% | -20.8% | US$7.4b | US$199.40 | PE522.7x | E44.3% | n/a | ||
0P8 | US$170.55 | -1.8% | -25.2% | US$7.4b | US$177.54 | PE522.7x | E44.3% | n/a | ||
P2NB34 | US$30.91 | 0% | -26.0% | US$7.4b | US$32.18 | PE522.7x | E44.3% | n/a |